Eli Lilly (NYSE: LLY) has been on a tear for the better part of the last decade, but the company has experienced a bit of a ...

Until recently, GLP-1s, a powerful new class of weight-loss drugs, were confined mostly to rich countries. Yet the World Obesity Federation, a charity, reckons that two-thirds of the world’s 1bn obese ...

Although findings from a large retrospective study supports these positive effects of taking a GLP-1, it’s unclear whether ...

Novo Nordisk NVO and Structure Therapeutics GPCR have emerged as noteworthy companies in the obesity space. A market leader ...

A Concordia-led research team has created one of the first reference charts showing how children's adipose (fat) and muscle ...

A Concordia-led research team has created one of the first reference charts showing how children's adipose (fat) and muscle ...

Pfizer enters the obesity drug market with a reasonably valued deal, while valuation remains attractive and technicals show ...

About six months ago, a series of patients came to me begging for weight-loss injections to manage obesity. As doctor who has ...

Childhood should be full of energy, exploration, and growth—but for many children today, those years are being shaped by a ...

A new definition of obesity endorsed by 76 health organizations could dramatically increase the number of Americans ...

Obesity experts have a proposed a 'radical overhaul' of how obesity is diagnosed, arguing BMI charts alone are not 'nuanced' ...